These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23385150)

  • 41. Outcomes in surgical stage I uterine papillary serous carcinoma.
    Havrilesky LJ; Secord AA; Bae-Jump V; Ayeni T; Calingaert B; Clarke-Pearson DL; Berchuck A; Gehrig PA
    Gynecol Oncol; 2007 Jun; 105(3):677-82. PubMed ID: 17355889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
    Klopp AH; Jhingran A; Ramondetta L; Lu K; Gershenson DM; Eifel PJ
    Gynecol Oncol; 2009 Oct; 115(1):6-11. PubMed ID: 19632709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma.
    Low JS; Wong EH; Tan HS; Yap SP; Chua EJ; Sethi VK; Soh LT; Low J; Tay EH; Chew SH
    Gynecol Oncol; 2005 Apr; 97(1):171-7. PubMed ID: 15790454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.
    Mundt AJ; Murphy KT; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1154-60. PubMed ID: 11483324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of "sandwich chemo-radiotherapy" and six cycles of chemotherapy followed by adjuvant radiotherapy in patients with stage IIIC endometrial cancer: a single center experience.
    Dogan NU; Yavas G; Yavas C; Ata O; Yılmaz SA; Celik C
    Arch Gynecol Obstet; 2013 Oct; 288(4):845-50. PubMed ID: 23553195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined chemotherapy regimen of carboplatin and paclitaxel as adjuvant treatment for papillary serous and clear cell endometrial cancer.
    Shechter-Maor G; Bruchim I; Ben-Harim Z; Altaras M; Fishman A
    Int J Gynecol Cancer; 2009 May; 19(4):662-4. PubMed ID: 19509567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant Pelvic Radiation "Sandwiched" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial.
    Frimer M; Miller EM; Shankar V; Girda E; Mehta K; Smith HO; Kuo DYS; Goldberg GL; Einstein MH
    Int J Gynecol Cancer; 2018 Nov; 28(9):1781-1788. PubMed ID: 30371562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy.
    Desai NB; Kiess AP; Kollmeier MA; Abu-Rustum NR; Makker V; Barakat RR; Alektiar KM
    Gynecol Oncol; 2013 Dec; 131(3):604-8. PubMed ID: 24055615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer.
    Alektiar KM; Makker V; Abu-Rustum NR; Soslow RA; Chi DS; Barakat RR; Aghajanian CA
    Gynecol Oncol; 2009 Jan; 112(1):142-5. PubMed ID: 19019418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer.
    Randall ME; Filiaci V; McMeekin DS; von Gruenigen V; Huang H; Yashar CM; Mannel RS; Kim JW; Salani R; DiSilvestro PA; Burke JJ; Rutherford T; Spirtos NM; Terada K; Anderson PR; Brewster WR; Small W; Aghajanian CA; Miller DS
    J Clin Oncol; 2019 Jul; 37(21):1810-1818. PubMed ID: 30995174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors.
    Landrum LM; Nugent EK; Zuna RE; Syzek E; Mannel RS; Moore KN; Walker JL; McMeekin DS
    Gynecol Oncol; 2014 Jan; 132(1):50-4. PubMed ID: 24219982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation.
    Dueñas-Gonzalez A; López-Graniel C; González-Enciso A; Cetina L; Rivera L; Mariscal I; Montalvo G; Gómez E; de la Garza J; Chanona G; Mohar A
    Ann Oncol; 2003 Aug; 14(8):1278-84. PubMed ID: 12881393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer.
    Lum MM; Belnap TW; Frandsen J; Brown AP; Sause WT; Soisson AP; Dodson MK; Werner T; Gaffney DK
    Am J Clin Oncol; 2015 Jun; 38(3):283-8. PubMed ID: 23774072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study.
    Kurnit KC; Nobre SP; Fellman BM; Iglesias DA; Lindemann K; Jhingran A; Eriksson AGZ; Ataseven B; Glaser GE; Mueller JJ; Westin SN; Soliman PT
    Gynecol Oncol; 2022 Dec; 167(3):452-457. PubMed ID: 36243601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
    Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary Fallopian Tube Carcinoma: A Single-Institution Experience of 101 Cases: A Retrospective Study.
    Bao L; Ding Y; Cai Q; Ning Y; Hu W; Xue X; Sun H; Hua K; Zhou X; Yi X
    Int J Gynecol Cancer; 2016 Mar; 26(3):424-30. PubMed ID: 26825825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
    Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
    Fakiris AJ; Moore DH; Reddy SR; Look KY; Yiannoutsos CT; Randall ME; Cardenes HR;
    Gynecol Oncol; 2005 Mar; 96(3):818-23. PubMed ID: 15721431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study.
    Mahdi H; Elshaikh MA; DeBenardo R; Munkarah A; Isrow D; Singh S; Waggoner S; Ali-Fehmi R; Morris RT; Harding J; Moslemi-Kebria M
    Gynecol Oncol; 2015 May; 137(2):239-44. PubMed ID: 25641568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.